BACKGROUND: Glioblastoma multiforme (GBM) is a high-grade glioma with poor prognosis. Identification of new biomarkers specific to GBM could help in disease diagnosis. We have developed and validated a bioinformatics method to predict proteins likely to be suitable as glioma biomarkers via a global microarray meta-analysis to identify uncharacterized genes consistently coexpressed with known glioma-associated genes. METHODS: A novel bioinformatics method was implemented called global microarray meta-analysis, using approximately 16,000 microarray experiments to identify uncharacterized genes consistently coexpressed with known glioma-associated genes. These novel biomarkers were validated as proteins highly expressed in human gliomas varying in tumor grades using immunohistochemistry. Glioma gene databases were used to assess delineation of expression of these markers in varying glioma grades and subtypes of GBM. RESULTS: We have identified 5 potential biomarkers-spondin1, Plexin-B2, SLIT3, fibulin-1, and LINGO1-that were validated as proteins highly expressed on the surface of human gliomas using immunohistochemistry. Expression of spondin1, Plexin-B2, and SLIT3 was significantly higher (P < .01) in high-grade gliomas than in low-grade gliomas. These biomarkers were significant discriminators in grade IV gliomas compared with either grade III or II tumors and also distinguished between GBM subclasses. CONCLUSIONS: This study strongly suggests that this type of bioinformatics approach has high translational potential to rapidly discern which poorly characterized proteins may be of clinical relevance.
BACKGROUND:Glioblastoma multiforme (GBM) is a high-grade glioma with poor prognosis. Identification of new biomarkers specific to GBM could help in disease diagnosis. We have developed and validated a bioinformatics method to predict proteins likely to be suitable as glioma biomarkers via a global microarray meta-analysis to identify uncharacterized genes consistently coexpressed with known glioma-associated genes. METHODS: A novel bioinformatics method was implemented called global microarray meta-analysis, using approximately 16,000 microarray experiments to identify uncharacterized genes consistently coexpressed with known glioma-associated genes. These novel biomarkers were validated as proteins highly expressed in humangliomas varying in tumor grades using immunohistochemistry. Glioma gene databases were used to assess delineation of expression of these markers in varying glioma grades and subtypes of GBM. RESULTS: We have identified 5 potential biomarkers-spondin1, Plexin-B2, SLIT3, fibulin-1, and LINGO1-that were validated as proteins highly expressed on the surface of humangliomas using immunohistochemistry. Expression of spondin1, Plexin-B2, and SLIT3 was significantly higher (P < .01) in high-grade gliomas than in low-grade gliomas. These biomarkers were significant discriminators in grade IV gliomas compared with either grade III or II tumors and also distinguished between GBM subclasses. CONCLUSIONS: This study strongly suggests that this type of bioinformatics approach has high translational potential to rapidly discern which poorly characterized proteins may be of clinical relevance.
Authors: Ruth A Pyle-Chenault; John A Stolk; David A Molesh; Dianne Boyle-Harlan; Patricia D McNeill; Elizabeth A Repasky; Zhong Jiang; Gary R Fanger; Jiangchun Xu Journal: Tumour Biol Date: 2005-08-09
Authors: Serenella M Pupa; William S Argraves; Stefania Forti; Patrizia Casalini; Valeria Berno; Roberto Agresti; Piera Aiello; Annamaria Invernizzi; Paola Baldassari; Waleed O Twal; Roberta Mortarini; Andrea Anichini; Sylvie Ménard; Scott W Argraves Journal: Oncogene Date: 2004-03-18 Impact factor: 9.867
Authors: Siva K Gandhapudi; Chibing Tan; Julie H Marino; Ashlee A Taylor; Christopher C Pack; Joel Gaikwad; C Justin Van De Wiele; Jonathan D Wren; T Kent Teague Journal: J Immunol Date: 2015-03-16 Impact factor: 5.422
Authors: Evgin Goceri; Behiye Goksel; James B Elder; Vinay K Puduvalli; Jose J Otero; Metin N Gurcan Journal: Int J Numer Method Biomed Eng Date: 2017-02-10 Impact factor: 2.747
Authors: Hailing Yang; Liang Yuan; Soichiro Ibaragi; Shuping Li; Robert Shapiro; Nil Vanli; Kevin A Goncalves; Wenhao Yu; Hiroko Kishikawa; Yuxiang Jiang; Alexander J Hu; Daniel Jay; Brent Cochran; Eric C Holland; Guo-Fu Hu Journal: Br J Cancer Date: 2022-04-13 Impact factor: 9.075
Authors: Holly Van Remmen; Willard M Freeman; Benjamin F Miller; Michael Kinter; Jonathan D Wren; Ann Chiao; Rheal A Towner; Timothy A Snider; William E Sonntag; Arlan Richardson Journal: Geroscience Date: 2021-10-04 Impact factor: 7.713
Authors: Chao Huang; Chenying Fu; Jonathan D Wren; Xuejun Wang; Feng Zhang; Yanhui H Zhang; Samuel A Connel; Taosheng Chen; Xin A Zhang Journal: Cell Mol Life Sci Date: 2018-03-27 Impact factor: 9.207